TrialMedicine2016

Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.

Yahya Dadjou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.